Royal Bank of Canada Has $611,000 Stock Holdings in Innovator IBD 50 ETF $FFTY

Royal Bank of Canada raised its position in shares of Innovator IBD 50 ETF (NYSEARCA:FFTY) by 3,222.5% in the first quarter, HoldingsChannel.com reports. The firm owned 18,274 shares of the company’s stock after purchasing an additional 17,724 shares during the quarter. Royal Bank of Canada’s holdings in Innovator IBD 50 ETF were worth $611,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. AlphaCore Capital LLC acquired a new position in shares of Innovator IBD 50 ETF during the fourth quarter valued at about $32,000. International Assets Investment Management LLC purchased a new position in shares of Innovator IBD 50 ETF during the fourth quarter valued at approximately $35,000. Simplex Trading LLC bought a new stake in Innovator IBD 50 ETF during the fourth quarter worth $41,000. Advisory Services Network LLC bought a new stake in Innovator IBD 50 ETF during the third quarter worth $43,000. Finally, Kestra Advisory Services LLC purchased a new stake in Innovator IBD 50 ETF in the 4th quarter valued at $72,000.

Innovator IBD 50 ETF Trading Down 0.2%

Shares of NYSEARCA:FFTY opened at $36.85 on Tuesday. The stock has a market cap of $79.23 million, a PE ratio of 30.34 and a beta of 1.47. The stock’s fifty day simple moving average is $39.19 and its two-hundred day simple moving average is $38.45. Innovator IBD 50 ETF has a 1-year low of $31.61 and a 1-year high of $44.08.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.